A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short Stature
Clinical trial NCT03255694 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03255694
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-12
- Primary completion
- 2030-06-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.